4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-19-006607
Chief Tech. Operations Officer sold 1,500 shares at an average $38.01 ($57,020)
- Chief Tech. Operations Officer acquired 1,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Newell Joe Chief Tech. Operations Officer | 2019-02-01 | Option exercise | +1,500 | $20.40 | $30,600 | 33,358 | D |
| Newell Joe Chief Tech. Operations Officer | 2019-02-01 | Sale | −1,000 | $37.80 | $37,800 | 32,358 | D |
| Newell Joe Chief Tech. Operations Officer | 2019-02-02 | Sale | −500 | $38.44 | $19,220 | 31,858 | D |
| Derivatives | |||||||
| Newell Joe Chief Tech. Operations Officer | 2019-02-01 | Option exercise · Employee Stock Option (Right to Buy) | −1,500 | 69,500 | D | ||
| Open-market sales · 1,500 sh · avg $38.01 · $57,020 | |||||||
Loading xslF345X03/doc4.xml…